{
    "1": {
        "question": "What method was used to track the fate of NK cells in vivo after recruitment into solid tumors?",
        "options": {
            "A": "Flow cytometry",
            "B": "Photo-labeling",
            "C": "Western blotting",
            "D": "ELISA",
            "E": "Mass spectrometry",
            "F": "I don't know"
        }
    },
    "2": {
        "question": "What was the main finding regarding NK cells after they entered the tumor microenvironment?",
        "options": {
            "A": "They increased their cytotoxicity",
            "B": "They rapidly lost effector functions",
            "C": "They became more proliferative",
            "D": "They started producing more cytokines",
            "E": "They migrated out of the tumor",
            "F": "I don't know"
        }
    },
    "3": {
        "question": "Which cytokine administration was found to prevent the loss of NK cell function and improve tumor control?",
        "options": {
            "A": "IL-2",
            "B": "IL-6",
            "C": "IL-10",
            "D": "IL-15",
            "E": "IL-17",
            "F": "I don't know"
        }
    },
    "4": {
        "question": "What characteristic did intratumoral NK cells adopt after recruitment into tumors?",
        "options": {
            "A": "Increased expression of CD49b",
            "B": "Decreased expression of CD49a",
            "C": "Expression of tissue-residency markers",
            "D": "Increased migration to lymph nodes",
            "E": "Enhanced production of IFN\u03b3",
            "F": "I don't know"
        }
    },
    "5": {
        "question": "What was the effect of NK cell depletion from established tumors on tumor growth?",
        "options": {
            "A": "It significantly reduced tumor growth",
            "B": "It had no impact on tumor growth",
            "C": "It increased tumor growth",
            "D": "It caused tumor regression",
            "E": "It led to metastasis",
            "F": "I don't know"
        }
    },
    "6": {
        "question": "Which integrin expression was used to distinguish cNK cells from tissue-resident NK cells and ILC1?",
        "options": {
            "A": "CD49a",
            "B": "CD49b",
            "C": "CD11a",
            "D": "CD11b",
            "E": "CD103",
            "F": "I don't know"
        }
    },
    "7": {
        "question": "What was the main conclusion regarding the role of TGF\u03b2 and PGE2 in NK cell function within tumors?",
        "options": {
            "A": "They enhance NK cell cytotoxicity",
            "B": "They completely recapitulate the tumor-retained NK cell phenotype in vitro",
            "C": "They partially recapitulate the tumor-retained NK cell phenotype in vitro",
            "D": "They have no effect on NK cell function",
            "E": "They increase NK cell migration",
            "F": "I don't know"
        }
    },
    "8": {
        "question": "What was the effect of IL-15:IL-15Ra complexes on NK cells within tumors?",
        "options": {
            "A": "They decreased NK cell numbers",
            "B": "They increased NK cell apoptosis",
            "C": "They enhanced NK cell effector functions",
            "D": "They reduced NK cell migration",
            "E": "They had no effect on NK cells",
            "F": "I don't know"
        }
    },
    "9": {
        "question": "What was the observed effect of hypoxia on NK cell effector functions in vitro?",
        "options": {
            "A": "Significant enhancement of effector functions",
            "B": "Complete loss of effector functions",
            "C": "Very modest changes in integrin and granzyme expression",
            "D": "Increased production of cytokines",
            "E": "No effect on effector functions",
            "F": "I don't know"
        }
    },
    "10": {
        "question": "What was the main finding regarding NK cells in human colorectal cancer (CRC) tumors?",
        "options": {
            "A": "They were highly cytotoxic",
            "B": "They adopted a resting, non-activated state",
            "C": "They were absent from the tumors",
            "D": "They were the main effector cells controlling tumor growth",
            "E": "They were more active than in normal tissue",
            "F": "I don't know"
        }
    },
    "11": {
        "question": "What was the effect of IL-15:IL-15Ra treatment on the phenotype of NK cells in tumors?",
        "options": {
            "A": "It caused a decrease in CD49a expression",
            "B": "It resulted in the emergence of a CD49a+ CD11b+ population",
            "C": "It led to the loss of CD11b expression",
            "D": "It had no effect on NK cell phenotype",
            "E": "It increased CD11b expression only",
            "F": "I don't know"
        }
    },
    "12": {
        "question": "What was the main method used to analyze the transcriptomic changes in NK cells over time?",
        "options": {
            "A": "Western blotting",
            "B": "Mass spectrometry",
            "C": "scRNA-sequencing",
            "D": "ELISA",
            "E": "qPCR",
            "F": "I don't know"
        }
    },
    "13": {
        "question": "What was the main finding regarding the expression of CD49a and CD11b in NK cells over time in the tumor?",
        "options": {
            "A": "CD49a expression decreased over time",
            "B": "CD11b expression increased over time",
            "C": "CD49a expression increased and CD11b expression decreased over time",
            "D": "Both CD49a and CD11b expression increased over time",
            "E": "Both CD49a and CD11b expression decreased over time",
            "F": "I don't know"
        }
    },
    "14": {
        "question": "What was the effect of NK cell depletion on tumor growth in the absence of T cells?",
        "options": {
            "A": "It significantly reduced tumor growth",
            "B": "It had no impact on tumor growth",
            "C": "It increased tumor growth",
            "D": "It caused tumor regression",
            "E": "It led to metastasis",
            "F": "I don't know"
        }
    },
    "15": {
        "question": "What was the main finding regarding the role of HIF-1\u03b1 in NK cell function within tumors?",
        "options": {
            "A": "HIF-1\u03b1 deletion significantly impaired tumor growth",
            "B": "HIF-1\u03b1 deletion had no significant impact on NK cell function",
            "C": "HIF-1\u03b1 deletion enhanced NK cell cytotoxicity",
            "D": "HIF-1\u03b1 deletion increased NK cell migration",
            "E": "HIF-1\u03b1 deletion reduced NK cell numbers",
            "F": "I don't know"
        }
    },
    "16": {
        "question": "What was the main conclusion regarding the potential of IL-15:IL-15Ra complexes in cancer therapy?",
        "options": {
            "A": "They are ineffective in enhancing NK cell function",
            "B": "They can block the loss of NK cell functions in the TME",
            "C": "They reduce NK cell numbers in tumors",
            "D": "They have no effect on tumor growth",
            "E": "They increase tumor metastasis",
            "F": "I don't know"
        }
    },
    "17": {
        "question": "What was the main finding regarding the expression of inhibitory receptors on NK cells over pseudotime?",
        "options": {
            "A": "Inhibitory receptor expression decreased over pseudotime",
            "B": "Inhibitory receptor expression remained constant over pseudotime",
            "C": "Inhibitory receptor expression increased over pseudotime",
            "D": "Inhibitory receptor expression was not analyzed",
            "E": "Inhibitory receptor expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "18": {
        "question": "What was the main finding regarding the production of CCL5 by NK cells after tumor entry?",
        "options": {
            "A": "CCL5 production increased after tumor entry",
            "B": "CCL5 production remained constant after tumor entry",
            "C": "CCL5 production was lost after tumor entry",
            "D": "CCL5 production was not analyzed",
            "E": "CCL5 production fluctuated randomly",
            "F": "I don't know"
        }
    },
    "19": {
        "question": "What was the main finding regarding the expression of granzyme A in NK cells over time in the tumor?",
        "options": {
            "A": "Granzyme A expression increased over time",
            "B": "Granzyme A expression remained constant over time",
            "C": "Granzyme A expression decreased over time",
            "D": "Granzyme A expression was not analyzed",
            "E": "Granzyme A expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "20": {
        "question": "What was the main finding regarding the expression of granzyme C in NK cells over time in the tumor?",
        "options": {
            "A": "Granzyme C expression increased over time",
            "B": "Granzyme C expression remained constant over time",
            "C": "Granzyme C expression decreased over time",
            "D": "Granzyme C expression was not analyzed",
            "E": "Granzyme C expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "21": {
        "question": "What was the main finding regarding the expression of perforin in NK cells over time in the tumor?",
        "options": {
            "A": "Perforin expression increased over time",
            "B": "Perforin expression remained constant over time",
            "C": "Perforin expression decreased over time",
            "D": "Perforin expression was not analyzed",
            "E": "Perforin expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "22": {
        "question": "What was the main finding regarding the expression of CD107a in NK cells over time in the tumor?",
        "options": {
            "A": "CD107a expression increased over time",
            "B": "CD107a expression remained constant over time",
            "C": "CD107a expression decreased over time",
            "D": "CD107a expression was not analyzed",
            "E": "CD107a expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "23": {
        "question": "What was the main finding regarding the expression of IFN\u03b3 in NK cells over time in the tumor?",
        "options": {
            "A": "IFN\u03b3 expression increased over time",
            "B": "IFN\u03b3 expression remained constant over time",
            "C": "IFN\u03b3 expression decreased over time",
            "D": "IFN\u03b3 expression was not analyzed",
            "E": "IFN\u03b3 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "24": {
        "question": "What was the main finding regarding the expression of CD69 in NK cells over time in the tumor?",
        "options": {
            "A": "CD69 expression increased over time",
            "B": "CD69 expression remained constant over time",
            "C": "CD69 expression decreased over time",
            "D": "CD69 expression was not analyzed",
            "E": "CD69 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "25": {
        "question": "What was the main finding regarding the expression of LAG-3 in NK cells over time in the tumor?",
        "options": {
            "A": "LAG-3 expression increased over time",
            "B": "LAG-3 expression remained constant over time",
            "C": "LAG-3 expression decreased over time",
            "D": "LAG-3 expression was not analyzed",
            "E": "LAG-3 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "26": {
        "question": "What was the main finding regarding the expression of NKG2A in NK cells over time in the tumor?",
        "options": {
            "A": "NKG2A expression increased over time",
            "B": "NKG2A expression remained constant over time",
            "C": "NKG2A expression decreased over time",
            "D": "NKG2A expression was not analyzed",
            "E": "NKG2A expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "27": {
        "question": "What was the main finding regarding the expression of CD16 in NK cells over time in the tumor?",
        "options": {
            "A": "CD16 expression increased over time",
            "B": "CD16 expression remained constant over time",
            "C": "CD16 expression decreased over time",
            "D": "CD16 expression was not analyzed",
            "E": "CD16 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "28": {
        "question": "What was the main finding regarding the expression of CD103 in NK cells over time in the tumor?",
        "options": {
            "A": "CD103 expression increased over time",
            "B": "CD103 expression remained constant over time",
            "C": "CD103 expression decreased over time",
            "D": "CD103 expression was not analyzed",
            "E": "CD103 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "29": {
        "question": "What was the main finding regarding the expression of CD200r1 in NK cells over time in the tumor?",
        "options": {
            "A": "CD200r1 expression increased over time",
            "B": "CD200r1 expression remained constant over time",
            "C": "CD200r1 expression decreased over time",
            "D": "CD200r1 expression was not analyzed",
            "E": "CD200r1 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "30": {
        "question": "What was the main finding regarding the expression of DNAM-1 in NK cells over time in the tumor?",
        "options": {
            "A": "DNAM-1 expression increased over time",
            "B": "DNAM-1 expression remained constant over time",
            "C": "DNAM-1 expression decreased over time",
            "D": "DNAM-1 expression was not analyzed",
            "E": "DNAM-1 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "31": {
        "question": "What was the main finding regarding the expression of EOMES in NK cells over time in the tumor?",
        "options": {
            "A": "EOMES expression increased over time",
            "B": "EOMES expression remained constant over time",
            "C": "EOMES expression decreased over time",
            "D": "EOMES expression was not analyzed",
            "E": "EOMES expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "32": {
        "question": "What was the main finding regarding the expression of T-bet in NK cells over time in the tumor?",
        "options": {
            "A": "T-bet expression increased over time",
            "B": "T-bet expression remained constant over time",
            "C": "T-bet expression decreased over time",
            "D": "T-bet expression was not analyzed",
            "E": "T-bet expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "33": {
        "question": "What was the main finding regarding the expression of KLRG1 in NK cells over time in the tumor?",
        "options": {
            "A": "KLRG1 expression increased over time",
            "B": "KLRG1 expression remained constant over time",
            "C": "KLRG1 expression decreased over time",
            "D": "KLRG1 expression was not analyzed",
            "E": "KLRG1 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "34": {
        "question": "What was the main finding regarding the expression of PD-1 in NK cells over time in the tumor?",
        "options": {
            "A": "PD-1 expression increased over time",
            "B": "PD-1 expression remained constant over time",
            "C": "PD-1 expression decreased over time",
            "D": "PD-1 expression was not analyzed",
            "E": "PD-1 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "35": {
        "question": "What was the main finding regarding the expression of CD69 in NK cells over time in the tumor?",
        "options": {
            "A": "CD69 expression increased over time",
            "B": "CD69 expression remained constant over time",
            "C": "CD69 expression decreased over time",
            "D": "CD69 expression was not analyzed",
            "E": "CD69 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "36": {
        "question": "What was the main finding regarding the expression of CD49a in NK cells over time in the tumor?",
        "options": {
            "A": "CD49a expression increased over time",
            "B": "CD49a expression remained constant over time",
            "C": "CD49a expression decreased over time",
            "D": "CD49a expression was not analyzed",
            "E": "CD49a expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "37": {
        "question": "What was the main finding regarding the expression of CD49b in NK cells over time in the tumor?",
        "options": {
            "A": "CD49b expression increased over time",
            "B": "CD49b expression remained constant over time",
            "C": "CD49b expression decreased over time",
            "D": "CD49b expression was not analyzed",
            "E": "CD49b expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "38": {
        "question": "What was the main finding regarding the expression of CD11b in NK cells over time in the tumor?",
        "options": {
            "A": "CD11b expression increased over time",
            "B": "CD11b expression remained constant over time",
            "C": "CD11b expression decreased over time",
            "D": "CD11b expression was not analyzed",
            "E": "CD11b expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "39": {
        "question": "What was the main finding regarding the expression of CD11a in NK cells over time in the tumor?",
        "options": {
            "A": "CD11a expression increased over time",
            "B": "CD11a expression remained constant over time",
            "C": "CD11a expression decreased over time",
            "D": "CD11a expression was not analyzed",
            "E": "CD11a expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "40": {
        "question": "What was the main finding regarding the expression of CD103 in NK cells over time in the tumor?",
        "options": {
            "A": "CD103 expression increased over time",
            "B": "CD103 expression remained constant over time",
            "C": "CD103 expression decreased over time",
            "D": "CD103 expression was not analyzed",
            "E": "CD103 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "41": {
        "question": "What was the main finding regarding the expression of CD200r1 in NK cells over time in the tumor?",
        "options": {
            "A": "CD200r1 expression increased over time",
            "B": "CD200r1 expression remained constant over time",
            "C": "CD200r1 expression decreased over time",
            "D": "CD200r1 expression was not analyzed",
            "E": "CD200r1 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "42": {
        "question": "What was the main finding regarding the expression of DNAM-1 in NK cells over time in the tumor?",
        "options": {
            "A": "DNAM-1 expression increased over time",
            "B": "DNAM-1 expression remained constant over time",
            "C": "DNAM-1 expression decreased over time",
            "D": "DNAM-1 expression was not analyzed",
            "E": "DNAM-1 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "43": {
        "question": "What was the main finding regarding the expression of EOMES in NK cells over time in the tumor?",
        "options": {
            "A": "EOMES expression increased over time",
            "B": "EOMES expression remained constant over time",
            "C": "EOMES expression decreased over time",
            "D": "EOMES expression was not analyzed",
            "E": "EOMES expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "44": {
        "question": "What was the main finding regarding the expression of T-bet in NK cells over time in the tumor?",
        "options": {
            "A": "T-bet expression increased over time",
            "B": "T-bet expression remained constant over time",
            "C": "T-bet expression decreased over time",
            "D": "T-bet expression was not analyzed",
            "E": "T-bet expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "45": {
        "question": "What was the main finding regarding the expression of KLRG1 in NK cells over time in the tumor?",
        "options": {
            "A": "KLRG1 expression increased over time",
            "B": "KLRG1 expression remained constant over time",
            "C": "KLRG1 expression decreased over time",
            "D": "KLRG1 expression was not analyzed",
            "E": "KLRG1 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "46": {
        "question": "What was the main finding regarding the expression of PD-1 in NK cells over time in the tumor?",
        "options": {
            "A": "PD-1 expression increased over time",
            "B": "PD-1 expression remained constant over time",
            "C": "PD-1 expression decreased over time",
            "D": "PD-1 expression was not analyzed",
            "E": "PD-1 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "47": {
        "question": "What was the main finding regarding the expression of CD69 in NK cells over time in the tumor?",
        "options": {
            "A": "CD69 expression increased over time",
            "B": "CD69 expression remained constant over time",
            "C": "CD69 expression decreased over time",
            "D": "CD69 expression was not analyzed",
            "E": "CD69 expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "48": {
        "question": "What was the main finding regarding the expression of CD49a in NK cells over time in the tumor?",
        "options": {
            "A": "CD49a expression increased over time",
            "B": "CD49a expression remained constant over time",
            "C": "CD49a expression decreased over time",
            "D": "CD49a expression was not analyzed",
            "E": "CD49a expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "49": {
        "question": "What was the main finding regarding the expression of CD49b in NK cells over time in the tumor?",
        "options": {
            "A": "CD49b expression increased over time",
            "B": "CD49b expression remained constant over time",
            "C": "CD49b expression decreased over time",
            "D": "CD49b expression was not analyzed",
            "E": "CD49b expression fluctuated randomly",
            "F": "I don't know"
        }
    },
    "50": {
        "question": "What was the main finding regarding the expression of CD11b in NK cells over time in the tumor?",
        "options": {
            "A": "CD11b expression increased over time",
            "B": "CD11b expression remained constant over time",
            "C": "CD11b expression decreased over time",
            "D": "CD11b expression was not analyzed",
            "E": "CD11b expression fluctuated randomly",
            "F": "I don't know"
        }
    }
}